Continuation of Treatment. The Provider agrees that in the event of MCO or IPA/ACO insolvency or termination of this contract for any reason, the Provider shall continue, until medically appropriate discharge or transfer, or completion of a course of treatment, whichever occurs first, to provide services pursuant to the subscriber contract or Medicaid Managed Care contract, to an enrollee confined in an inpatient facility, provided the confinement or course of treatment was commenced during the paid premium period. For purposes of this clause, the term “Provider” shall include the IPA/ACO and the IPA/ACO’s contracted Providers if this Agreement is between the MCO and an IPA/ACO. This provision shall survive termination of this Agreement.
Continuation of Treatment. CONTRACTOR shall provide justification for treatment to Clients who have been on methadone maintenance for a period of two (2) years, and annually thereafter as per Title 9, Section 10410. Justification shall be provided by the Medical Director or program physician and noted in Clients files. Without said justification the medical director or program physician shall discontinue a Client’s maintenance services.
Continuation of Treatment. Upon termination of this Agreement, except in the case of adverse reasons on the part of the Provider, Provider shall continue to provide Covered Services pursuant to all of the terms and conditions set forth in the Agreement to Members who are under the care of Provider at the time of termination for those specific conditions for which Member is under the care of Provider, and in accordance with the limitations and mandated time period applicable by Law to each Health Plan to preserve the continuity of care for those Members. As required by Law, in the event of a Health Plan’s or the Company’s insolvency or other cessation of operations, Provider shall continue to provide Covered Services through the period for which dues or premiums have been paid, or if a Member is confined in a facility on the date of insolvency or other cessation of operations, until the Member can be discharged in accord with an appropriate professional standard of care or Member’s benefits expire.
Continuation of Treatment. CONTRACTOR shall provide justification for 22 treatment to Clients who have been on methadone maintenance for a period of two (2) years, and 23 annually thereafter. Justification shall be provided by the Medical Director and noted in Clients’ files. 24 CONTRACTOR shall ensure that no Maintenance Client is enrolled for more than one (1) year from 25 admission date on COUNTY funding and that no Detoxification Client is enrolled for more than one (1) 26 detox episode per fiscal year, unless approved by ADMINISTRATOR. COUNTY funding is designed 27 to be a short-term stabilizer with the Client progressing to longer-term self- sustainment. Only those 28 Clients with special circumstances will be allowed to remain on Maintenance funding for up to two (2) 29 years of their admission unless otherwise approved by ADMINISTRATOR.
Continuation of Treatment. CONTRACTOR shall provide justification for 23 treatment to ParticipantsClients who have been on methadone maintenance for a period of two (2) years, 24 and annually thereafter. Justification shall be provided by the Medical Director and noted in 25 ParticipantsClients files. CONTRACTOR shall ensure that no Maintenance ParticipantClient is enrolled 26 for more than one (1) year from admission date on COUNTY funding and that no Detoxification 27 ParticipantClient is enrolled for more than one (1) detox episode per fiscal year, unless approved by 28 ADMINISTRATOR. CONTRACTOR shall provide ADMINISTRATOR with written updates for each 29 Maintenance Participant every sixty (60) calendar days from date of admission regarding progress toward 30 employment or obtainment of a third party payor(s) for a projected transition from COUNTY funding. 31 COUNTY funding is designed to be a short-term stabilizer with the ParticipantClient progressing to 32 longer-term self- sustainment. Only those ParticipantsClients with special circumstances as approved by 33 ADMINISTRATOR will be allowed to remain on Maintenance funding for up to two (2) years of their 34 admission unless otherwise approved by ADMINISTRATOR.
Continuation of Treatment. CONTRACTOR shall provide justification for director or program physician shall discontinue a Client’s maintenance services.
Continuation of Treatment. CONTRACTOR shall provide updated justification for 28 treatment for Clients who have been on methadone maintenance for a period of one (1) year, and 29 provide this justification annually thereafter as per Title 9, Section 10410. Justification shall be provided 30 by the Medical Director or program physician and noted in Client’s file. Without said justification the 31 medical director or program physician shall discontinue Client’s maintenance services. 32 N. PERFORMANCE OBJECTIVES AND OUTCOMES – CONTRACTOR shall meet the 33 following performance Objectives and Outcomes:
34 1. Achieve a goal of twenty percent (20%) or fewer of all unduplicated Clients who test 35 positive for illicit drugs after an enrollment of ninety (90) calendar days. 36 //
37 2. Achieve a goal of retaining at least seventy percent (70%) of Clients who are enrolled each CALIFORNIA TREATMENT SERVICES, LLC DBA RECOVERY SOLUTIONS OF SANTA XXX MA-042-23010943 1 month. Retention rates will be based on the number of Clients who either remain in treatment or 2 successfully complete treatment within the month.
3 3. Achieve a goal of at least seventy percent (70%) of unduplicated Clients who after an 4 enrollment of ninety (90) calendar days self-report being able to lead a productive lifestyle. A 5 productive lifestyle includes employment, being enrolled in school, becoming a caretaker, or community 6 volunteer.
7 4. Adhere to the National Standards for Culturally and Linguistically Appropriate Services in 8 Health and Health Care and respond to each standard as directed by HCA.
Continuation of Treatment. Corner Clinic may use and/or disclose your PHI to ensure continuation of care by checking on your progress or notifying you of received test results.
Continuation of Treatment. If this Agreement is terminated and Facility is treating a Member with recognized Special Circumstances, Cigna-HealthSpring will continue to reimburse Facility in accordance with this Agreement for the continued provision of Covered Services to that Member for a period of up to ninety (90) days for a Member of Special Circumstances (or six (6) months in the case of a Member of Special Circumstances with a terminal medical condition). During this time, Facility may not seek payment from the Member for any amount for which the Member would not be responsible if the Facility or Facility location, as applicable, were still a Participating Provider. This section will not apply if the Agreement is terminated immediately by Cigna-HealthSpring. This section shall survive termination of the Agreement for any reason.
Continuation of Treatment. In subjects who do not have evidence of clinical or radiographic disease progression and who do not experience unacceptable toxicity, additional cycles of tazemetostat beyond Cycle 1 may be given at the Investigator’s discretion with the subject’s or his/her legal representative consent. Prior to declaring progressive disease, the Investigator should be certain that special circumstances on progression defined by RECIST 1.1 are not met. In these situations of equivocal findings of progression, subjects may continue treatment until the next scheduled disease assessment. If progression is confirmed, the date of the previous assessment will be used as the date of disease progression. The required hematologic parameters for continuation of treatment for the second and subsequent cycles are the following: • Platelet count must be ≥50 × 109/L • ANC ≥1.0 × 109/L, and • Any Grade 3 or higher toxicity must have resolved to Grade 1 or baseline Study treatment may be interrupted for up to 14 days. Treatment interruptions longer than 14 days need Medical Monitor approval to proceed.
